EXEMESTANE TABLETS 25 MG
Categories:,
EXEMESTANE TABLETS 25 MG

Download as PDF
Enquire Now

Description

PRODUCT DESCRIPTION:

 

Exemestane 25 MG Tablets is a potent, steroidal aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels, thereby slowing or stopping the growth of hormone-sensitive tumors.

Exemestane is widely recommended as part of adjuvant therapy following tamoxifen or for advanced-stage breast cancer management.

Manufactured under stringent GMP-certified conditions, PHARMET offers Exemestane in export-ready packaging formats, with regulatory support for smooth market entry.

Formulation & Presentation:

  • Dosage Form: Tablets
  • Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
  • Available Strengths:
    • Mifepristone 25 MG Tablets
  • Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

  • Adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women
  • Treatment of advanced breast cancer after progression following anti-estrogen therapy

Side Effects:

  • COMMON:
    • Hot flashes
    • Joint pain
    • Fatigue
    • Increased sweating
    • Nausea
  • SERIOUS (RARE):
    • Osteoporosis or bone fractures
    • Depression or mood changes
    • Liver function abnormalities
    • Cardiovascular events (rare but reported)
  • PRECAUTIONS:
    • Not recommended for premenopausal women
    • Monitor bone mineral density regularly
    • Use with caution in patients with hepatic or renal impairment
    • Periodic liver function tests advised

Reviews

There are no reviews yet.

Be the first to review “EXEMESTANE TABLETS 25 MG”

Your email address will not be published. Required fields are marked *

12345

TECHNICAL INFORMATION

Product Specifications:

  • HSN Code: To be assigned per international classification standards
  • Weight: Approx. 40g per Carton (With Packaging)
  • Dimensions: (15x1x8 CMS)
  • Shelf Life (Subject To Country Specific Guidelines): 24 to 36 months from date of manufacture or as per label specifications
  • Storage: Store below 25°C. Protect from moisture and direct sunlight.

Regulatory Status & Supply Information:

  • Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
  • Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
  • Stability: Zone IVB Compliant
  • MOQ: Negotiable. Based on market & registration status
  • Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

  • Government health agencies and reproductive health programs
  • Pharmaceutical distributors focusing on women’s health
  • NGOs and public health organizations offering safe reproductive care
  • Hospitals and clinics providing medical abortion services
  • Ethical procurement teams sourcing WHO/GMP-certified hormonal agents

Why Source from PHARMET?

  • Oncology-focused distributors in emerging and regulated markets
  • Government tenders and hospital procurement departments
  • Cancer foundations and treatment support NGOs
  • Pharma wholesalers serving LATAM, Africa, Southeast Asia
  • Regulatory-compliant buyers seeking dossier-backed hormone therapies

CONTACT DETAILS:

Related items